Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders

作者: Kristian Winge

DOI: 10.1016/B978-0-444-63247-0.00019-5

关键词:

摘要: Progressive neurodegenerative disorders are devastating diseases with often fatal outcomes. Lower urinary tract symptoms (LUTS) add to morbidity and increase the risk of becoming dependent on help others (e.g., nursing-home referral). In Parkinson's disease (PD), specific loss dopaminergic neurons in substantia nigra possibly also ventral tegmental area induces neurogenic bladder control through dysfunction a complex network which selective disinhibition reflexes is lost. PD, more than 60% patients have troublesome symptoms, 30% experience incontinence, though not daily. atypical parkinsonism, including multiple system atrophy, LUTS highly prevalent, onset comparison other autonomic motor may serve as diagnostic marker. Less known about pathophysiology incontinence Alzheimer's disease, but higher cognitive function attention self-management play role. Incontinence major factor for independence. The pathophysiologic mechanisms hence important roles patient quality life. Nocturia, urgency well poor emptying most common symptoms. These interact core disorders, increasing infection. rarer neurogenerative disorder be present, commonly spinal cord involvement. systematic careful tracking evaluation using non-invasive techniques, conservative management pharmacologic treatments can markedly improve lives their caregivers.

参考文章(172)
R.O. Beck, C.D. Betts, Clare J. Fowler, Genitourinary Dysfunction in Multiple System Atrophy: Clinical Features and Treatment in 62 Cases The Journal of Urology. ,vol. 151, pp. 1336- 1341 ,(1994) , 10.1016/S0022-5347(17)35246-1
Günther Deuschl, Steffen Paschen, Karsten Witt, Clinical outcome of deep brain stimulation for Parkinson’s disease Handbook of Clinical Neurology. ,vol. 116, pp. 107- 128 ,(2013) , 10.1016/B978-0-444-53497-2.00010-3
Yitzhak Berger, Jerry G. Blaivas, E.R. DeLaRocha, Jesus M. Salinas, Urodynamic Findings in Parkinson’s Disease The Journal of Urology. ,vol. 138, pp. 836- 838 ,(1987) , 10.1016/S0022-5347(17)43390-8
Tage Hald, William E. Bradley, The urinary bladder, neurology and dynamics Williams & Wilkins. ,(1982)
Tamara Pringsheim, Nathalie Jette, Alexandra Frolkis, Thomas D.L. Steeves, The prevalence of Parkinson's disease: A systematic review and meta‐analysis Movement Disorders. ,vol. 29, pp. 1583- 1590 ,(2014) , 10.1002/MDS.25945
Kaycee M. Sink, Joseph Thomas, Huiping Xu, Bruce Craig, Steven Kritchevsky, Laura P. Sands, Dual Use of Bladder Anticholinergics and Cholinesterase Inhibitors: Long-Term Functional and Cognitive Outcomes Journal of the American Geriatrics Society. ,vol. 56, pp. 847- 853 ,(2008) , 10.1111/J.1532-5415.2008.01681.X
Juho Uusvaara, Kaisu H. Pitkala, Pentti J. Tienari, Hannu Kautiainen, Reijo S. Tilvis, Timo E. Strandberg, Association Between Anticholinergic Drugs and Apolipoprotein E ɛ4 Allele and Poorer Cognitive Function in Older Cardiovascular Patients: A Cross-Sectional Study Journal of the American Geriatrics Society. ,vol. 57, pp. 427- 431 ,(2009) , 10.1111/J.1532-5415.2008.02129.X
Akira Tsujimura, Yoichi Yamamoto, Saburo Sakoda, Hidenobu Okuda, Keisuke Yamamoto, Shinichiro Fukuhara, Iwao Yoshioka, Hiroshi Kiuchi, Tetsuya Takao, Yasushi Miyagawa, Norio Nonomura, Finger taps and constipation are closely related to symptoms of overactive bladder in male patients with Parkinson's disease. International Journal of Urology. ,vol. 21, pp. 69- 73 ,(2014) , 10.1111/IJU.12186
Livia Brusa, Enrico Finazzi Agrò, Filomena Petta, Francesco Sciobica, Sara Torriero, Emanuele Lo Gerfo, Cesare Iani, Paolo Stanzione, Giacomo Koch, Effects of inhibitory rTMS on bladder function in Parkinson's disease patients. Movement Disorders. ,vol. 24, pp. 445- 448 ,(2009) , 10.1002/MDS.22434